Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Capital Rx
United States
- New York, New York
- 14/08/2023
- Unknown
- Undisclosed Amount
Capital Rx is a healthcare technology company changing the way prescription drugs are priced, and patients are cared for in America. As a Certified B Corp™, Capital Rx is executing its mission through a Single Ledger Model™, the industry’s first ethical framework for drug pricing. The company’s cloud-native enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem in one system, empowering Capital Rx to deliver exceptional service to its commercial, Medicare, and Medicaid clients and members 24/7, 365 days a year. Together with its clients, Capital Rx is reimagining the administration of pharmacy benefits and rebuilding trust in healthcare.
- Industry Hospital & Health Care
- Website https://www.cap-rx.com/
- LinkedIn https://www.linkedin.com/company/cap-rx/about/
Related People
A. J. LoiaconoFounder
United States -
New York, New York
On a mission to develop the technology infrastructure our country requires, for the healthcare system patients deserve.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)